HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Gut Microbiota Implications in Cancer

Cancer is a complex disease that is the world's second biggest cause of mortality. Numerous studies in recent years have underlined the dual significance of the gut microbiota in sustaining the health of the host. The term "gut microbiota" refers to the diverse population of commensal microorganisms, mainly bacteria but also fungi, archaea, and viruses that populate the intestinal tract, particularly the large intestine, and it can be thought of as one factor to which we are constantly exposed, at high doses, throughout our lives. The gastro-intestinal resident bacteria and the human body interact at a sophisticated level in the gut. Gut bacteria can produce a variety of metabolites and bioproducts that help to maintain homeostasis in both the host and the gut.

  • Gut Microbiota and Host’s Tumorigenesis
  • Microbial biomarkers
  • Gut Microbiota and the Inflammasomes
  • Faecal Microbiota Transplantation (FMT)
  • Probiotics in Cancer
  • Bacteria Based Therapies

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp